News Focus
News Focus
Followers 118
Posts 9696
Boards Moderated 0
Alias Born 02/03/2018

Re: ATLnsider post# 798930

Thursday, 11/20/2025 5:11:37 PM

Thursday, November 20, 2025 5:11:37 PM

Post# of 821333
I know I'm bouncing back and forth here, but that is true. The latest PR referenced scaling requirements, NOT approval.
I would go even further by saying an intermediate approval may have provided the company with the confidence needed to pull the latest triggers. The MHRA has to know how under pressure a pre revenue company is to demand a 6 month build out, without giving anything back for it. The idea that the MHRA couldn't care less, and think, "meh, let them eat cake for another six months.." is also not reasonable to believe.



NWBio has always consistently said that they will start meeting patient demand by manufacturing DCVax-L in the Class B suite at the Sawston facility after initial approval.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News